Page last updated: 2024-09-02

2-acetyl-4(5)-tetrahydroxybutylimidazole and Autoimmune Disease

2-acetyl-4(5)-tetrahydroxybutylimidazole has been researched along with Autoimmune Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Augeri, DJ; Bagdanoff, JT; Barbosa, J; Baugh, SD; Bednarz, M; Bruce, D; Carlsen, M; Carson, KG; Courtney, LF; Digeorge-Foushee, AM; Donoviel, MS; Fu, Q; Gardyan, M; Gopinathan, S; Hazelwood, J; Jessop, TC; Kimball, SD; Kramer, J; Lai, Z; Layek, S; Liu, Q; Main, A; Moran, L; Nguyen, H; Nouraldeen, A; O'Neill, E; Oravecz, T; Smith, T; Sun, W; Swaffield, J; Tarver, J; Taylor, J; Terranova, KM; Wilson, A; Yan, J; Yu, S; Zhang, H1

Other Studies

1 other study(ies) available for 2-acetyl-4(5)-tetrahydroxybutylimidazole and Autoimmune Disease

ArticleYear
Inhibition of sphingosine-1-phosphate lyase for the treatment of autoimmune disorders.
    Journal of medicinal chemistry, 2009, Jul-09, Volume: 52, Issue:13

    Topics: Administration, Oral; Aldehyde-Lyases; Animals; Autoimmune Diseases; Enzyme Inhibitors; Imidazoles; Lymphocyte Count; Mice; Structure-Activity Relationship

2009